Bisphosphonate-related osteonecrosis of the jaw(BRONJ)¿¡ ´ëÇÑ biochemical bone makrkers¿Í ¾Ç°ñ±«»ç¿Í ¿¬°üµÈ nonbisphosphonate drugs
Biochemical bone markers of bisphosphonate-related osteonacrosis of the jaw (BRONJ) and nonbiosphosphonate drugs in osteonecrosis of the jaw

´ëÇÑÄ¡°úÀÇ»çÇùȸÁö 2014³â 52±Ç 4È£ p.203 ~ p.217

ÀÌ´ö¿ø(Lee Deok-Won) - °æÈñ´ëÇб³ Ä¡ÀÇÇÐÀü¹®´ëÇпø ±¸°­¾Ç¾È¸é¿Ü°úÇб³½Ç
ÀÌÇö¿ì(Lee Hyun-Woo) - °æÈñ´ëÇб³ Ä¡ÀÇÇÐÀü¹®´ëÇпø ±¸°­¾Ç¾È¸é¿Ü°úÇб³½Ç
±Ç¿ë´ë(Kwon Yong-Dae) - °æÈñ´ëÇб³ Ä¡ÀÇÇÐÀü¹®´ëÇпø ±¸°­¾Ç¾È¸é¿Ü°úÇб³½Ç

Abstract

Ű¿öµå

bisphosphonate-related osteonacrosis of the jaw (BRONJ), Biochemical bone marker, nonbiosphosphonate drugs
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Ű¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆÇ³âµµ(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå